Gilead’s next step on coronavirus
HCQ Misinformation Can Be Deadly: Let Patients Decide
Use of antihypertensive drugs generates pressure-packed debate in COVID-19 era
From the research lab to your doctor's office – here's what happens in phase 1, 2, 3 drug trials
Dying virtually: Pandemic drives medically assisted deaths online
FDA approval for Brilinta, EU recommendation for Lynparza
Study shows hydroxychloroquine’s harmful effects on heart rhythm
Atriva takes MEK inhibitor into phase 2 for COVID-19
3 “Strong Buy” Biotech Stocks Under $5 With Explosive Upside Potential
WHO halts hydroxychloroquine trial in COVID-19 following safety concerns
COVID-19 prevention trial opens for high-risk healthcare workers
Modified clinical trial protocol created in response to urgency of COVID-19 pandemic